Skip to main content

Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.

Publication ,  Journal Article
Santos, RP; Sánchez, PJ; Mejias, A; Benjamin, DK; Walsh, TJ; Patel, S; Jafri, HS
Published in: Pediatr Infect Dis J
April 2007

Treatment options for primary cutaneous aspergillosis in neonates are limited by the lack of pharmacokinetic and safety data of newer antifungal agents that are effective against Aspergillus spp. We report the successful treatment of cutaneous aspergillosis in an extremely low-birth-weight preterm infant with liposomal amphotericin B, voriconazole and micafungin, and provide pharmacokinetic profiles for voriconazole and micafungin.

Duke Scholars

Published In

Pediatr Infect Dis J

DOI

ISSN

0891-3668

Publication Date

April 2007

Volume

26

Issue

4

Start / End Page

364 / 366

Location

United States

Related Subject Headings

  • Voriconazole
  • Triazoles
  • Treatment Outcome
  • Pyrimidines
  • Peptides, Cyclic
  • Pediatrics
  • Micafungin
  • Lipoproteins
  • Lipopeptides
  • Infant, Premature, Diseases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Santos, R. P., Sánchez, P. J., Mejias, A., Benjamin, D. K., Walsh, T. J., Patel, S., & Jafri, H. S. (2007). Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin. Pediatr Infect Dis J, 26(4), 364–366. https://doi.org/10.1097/01.inf.0000258698.98370.89
Santos, Roberto P., Pablo J. Sánchez, Asuncion Mejias, Daniel K. Benjamin, Thomas J. Walsh, Sanjay Patel, and Hasan S. Jafri. “Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.Pediatr Infect Dis J 26, no. 4 (April 2007): 364–66. https://doi.org/10.1097/01.inf.0000258698.98370.89.
Santos RP, Sánchez PJ, Mejias A, Benjamin DK, Walsh TJ, Patel S, et al. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin. Pediatr Infect Dis J. 2007 Apr;26(4):364–6.
Santos, Roberto P., et al. “Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.Pediatr Infect Dis J, vol. 26, no. 4, Apr. 2007, pp. 364–66. Pubmed, doi:10.1097/01.inf.0000258698.98370.89.
Santos RP, Sánchez PJ, Mejias A, Benjamin DK, Walsh TJ, Patel S, Jafri HS. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin. Pediatr Infect Dis J. 2007 Apr;26(4):364–366.

Published In

Pediatr Infect Dis J

DOI

ISSN

0891-3668

Publication Date

April 2007

Volume

26

Issue

4

Start / End Page

364 / 366

Location

United States

Related Subject Headings

  • Voriconazole
  • Triazoles
  • Treatment Outcome
  • Pyrimidines
  • Peptides, Cyclic
  • Pediatrics
  • Micafungin
  • Lipoproteins
  • Lipopeptides
  • Infant, Premature, Diseases